<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000751.v1.p1" parentStudy="phs000751.v1.p1" createDate="2014-05-23" modDate="2014-06-25">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>David A. Schwartz, MD</td><td>University of Colorado, Denver - Aurora, CO, USA</td></tr>
		<tr><td>Funding Sources</td><td>R01 HL095393</td><td>National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Funding Sources</td><td>R01 HL097163</td><td>National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Funding Sources</td><td>P01 HL092870</td><td>National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Funding Sources</td><td>RC2 HL101715</td><td>National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>GWAS in Fibrosing Interstitial Lung Disease</StudyNameEntrez>
	<StudyNameReportPage>GWAS in Fibrosing Interstitial Lung Disease</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Case-Control</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>This study was a case-control genome-wide association study of 1616 non-Hispanic white cases and 4683 controls. Under an additive model for the minor allele at each SNP, we identified 19 SNPs, representing 7 chromosomal locations (5p15, 6p24, 7q22, 11p15, 15q14-15, 17q21, and 19p13), with genome-wide significant (P &#60; 5x10-8) associations using the discovery samples included in this submission. We genotyped the 19 genome-wide significant SNPs in addition to 178 SNPs with 5x10-8 &#60; P-value &#60;.0001 and found 4 additional loci (3q26, 4q22, 10q24, and13q34) with genome-wide significant SNPs in the meta-analysis.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p>We used standard criteria established by the American Thoracic Society/European Respiratory Society in 2001 (<a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=11790668">Am J Respir Crit Care Med., 2002</a>) to determine diagnostic classification of all patients in the discovery and replication phases. We excluded cases with known explanations for development of fibrotic IIP including infections, systemic disorders, or relevant exposures (e.g. asbestos). We included only non-Hispanic white participants.</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="23583980"/>
		</Publication>
		<Publication>
			<Pubmed pmid="21506741"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Lung Diseases, Interstitial"/>
		<Disease vocab_source="MESH" vocab_term="Idiopathic Interstitial Pneumonias"/>
		<Disease vocab_source="MESH" vocab_term="Idiopathic Pulmonary Fibrosis"/>
		<Disease vocab_source="MESH" vocab_term="Familial Idiopathic Pulmonary Fibrosis"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>David A. Schwartz, MD</AttName>
			<Institution>University of Colorado, Denver - Aurora, CO, USA</Institution>
		</Header>
		<Header title="Funding Sources">
			<AttName>R01 HL095393</AttName>
			<Institution>National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Sources">
			<AttName>R01 HL097163</AttName>
			<Institution>National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Sources">
			<AttName>P01 HL092870</AttName>
			<Institution>National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Sources">
			<AttName>RC2 HL101715</AttName>
			<Institution>National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Sources">
			<AttName>U01 HL089897</AttName>
			<Institution>National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Sources">
			<AttName>U01 HL089856</AttName>
			<Institution>National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Sources">
			<AttName>U01 HL108642</AttName>
			<Institution>National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Sources">
			<AttName>P50 HL0894932</AttName>
			<Institution>National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Sources">
			<AttName>1I01BX001534</AttName>
			<Institution>National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Sources">
			<AttName>The Dorothy P. and Richard P. Simmons Center</AttName>
			<Institution>Pittsburgh, PA, USA</Institution>
		</Header>
		<Header title="Funding Sources">
			<AttName>InterMune, Inc</AttName>
			<Institution>Brisbane, CA, USA</Institution>
		</Header>
		<Header title="Genotyping Center">
			<AttName>Mark Lathrop, PhD</AttName>
			<Institution>Fondation 				Jean Dausset, Centre d&#39;&#201;tude du Polymorphisme Humain, Paris, France</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<StudyHistory><![CDATA[
<p>This study release consists of "cases" only, as approval to deposit "controls" was not available.</p>]]>
	</StudyHistory>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="DS-LD-IRB-PUB" longName="Disease-Specific (Lung Disease, IRB, PUB)"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NHLBI</DacName>
      <DacFullName>National Heart, Lung, and Blood Institute DAC</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000751.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>yes</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000751.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000751.v1.p1" FileName="GWAS_fILDt_duc.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>Disease-Specific (Lung Disease, IRB, PUB)</ConsentName>
        <ConsentAbbrev>DS-LD-IRB-PUB</ConsentAbbrev>
        <UseLimitation>Use of the data must be related to Lung Disease.
Requestor must provide documentation of local IRB approval.
Requestor agrees to make results of studies using the data available to the larger scientific community.
Data is limited to use for lung disease research only.  Full or expedited IRB approval is required.</UseLimitation>
        <IrbRequired>Yes</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>

<Analyses>
	<Analysis pha="3858" genomeBuild="37.1" snpBuild="132" analysisType="">
		<Description>Analysis description: We performed a case-control GWAS of 1,616 cases and 4,683 controls (genotypes for the controls are not approved for release to dbGaP). All subjects were whole-genome genotyped on a Illumina Human 660W Quad BeadChip assay. Disease status for cases was determined using criteria established by the American Thoracic Society/European Respiratory Society.</Description>
		<Method>categorical analysis</Method>
		<GtyPlatform probeNum="592839" snpBatchId="1048965">
			<Vendor>Illumina</Vendor>
			<VendorURL>File Name,Human660W-Quad_v1_A.bpm Assay Format,Infinium HD Super Date Manufactured,8/26/2008 Loci Count ,657366</VendorURL>
			<Platform>Human660W-Qual_v1_A</Platform>
		</GtyPlatform>
		<Comment></Comment>
	</Analysis>
</Analyses>

</Study>

</Studies>

</GaPExchange>
